Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 1
1952 2
1953 2
1954 3
1955 5
1956 7
1957 2
1958 2
1959 4
1960 2
1961 2
1962 3
1963 3
1964 2
1965 2
1966 6
1967 5
1968 5
1969 4
1970 7
1971 7
1972 2
1973 2
1974 1
1975 1
1976 1
1977 2
1978 1
1979 7
1980 4
1981 2
1982 9
1983 3
1984 2
1985 8
1986 3
1987 3
1988 4
1989 4
1990 2
1991 6
1992 4
1993 2
1994 2
1995 7
1996 6
1998 1
1999 2
2000 3
2001 4
2002 2
2003 4
2004 1
2005 2
2006 1
2007 3
2008 8
2009 5
2010 7
2011 8
2012 17
2013 20
2014 18
2015 17
2016 16
2017 21
2018 22
2019 35
2020 33
2021 32
2022 30
2023 39
2024 28
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

514 results

Results by year

Filters applied: . Clear all
Page 1
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT Investigator Study Group. Howard JF Jr, et al. Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9. Lancet Neurol. 2021. PMID: 34146511 Clinical Trial.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Interstitial lung disease in systemic sclerosis: a simple staging system.
Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU. Goh NS, et al. Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi: 10.1164/rccm.200706-877OC. Epub 2008 Mar 27. Am J Respir Crit Care Med. 2008. PMID: 18369202 Clinical Trial.
Is Ba3In2O6a high-Tcsuperconductor?
Hensling FVE, Dahliah D, Smeaton MA, Shrestha B, Show V, Parzyck CT, Hennighausen C, Kotsonis GN, Rignanese GM, Barone MR, Subedi I, Disa AS, Shen KM, Faeth BD, Bollinger AT, Božović I, Podraza NJ, Kourkoutis LF, Hautier G, Schlom DG. Hensling FVE, et al. J Phys Condens Matter. 2024 May 9;36(31). doi: 10.1088/1361-648X/ad42f3. J Phys Condens Matter. 2024. PMID: 38657622
Superconductivity in a strange metal.
Wu J, Bozovic I. Wu J, et al. Sci Bull (Beijing). 2023 May 15;68(9):851-853. doi: 10.1016/j.scib.2023.03.038. Epub 2023 Mar 27. Sci Bull (Beijing). 2023. PMID: 37031079 No abstract available.
Active Biomechanics of Sensory Hair Bundles.
Bozovic D. Bozovic D. Cold Spring Harb Perspect Med. 2019 Nov 1;9(11):a035014. doi: 10.1101/cshperspect.a035014. Cold Spring Harb Perspect Med. 2019. PMID: 30323015 Free PMC article. Review.
514 results